Literature DB >> 21598109

Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma.

Qing Liu1, Guo-Dong Lv, Xu Qin, Yue-Hua Gen, Shu-Tao Zheng, Tao Liu, Xiao-Mei Lu.   

Abstract

To investigated the role of microRNA (miRNA) let-7 and its regulation on high mobility group A2 (HMGA2) protein expression in esophageal squamous cell carcinoma (ESCC). Let-7 expressions were detected in esophageal cancer cell line Eca109, and 45 paired of fresh ESCC and normal adjacent tissues (NAT) by real-time quantitative PCR (qRT-PCR). To evaluate the role of let-7 and HMGA2, cell proliferations were analyzed with synthetic let-7 mimics- or its inhibitor-transfected cells. Moreover, expressions of HMGA2 were performed by western blotting and further confirmed by 150 paired of formalin-fixed, paraffin-embeded (FFPE) ESCC and NAT by immunohistochemistry (IHC). In Eca109, when transfected with let-7 mimics, accumulation of let-7 was obviously suppressed cell proliferation with approximately 14%. Conversely, when Eca109 transfected with let-7 inhibitor, expression of let-7 was declined, which promoted cell proliferation with approximately 16%. Both of them had no effect on the level of HMGA2 mRNA. The transcription of let-7 inversely correlated with HMGA2 protein. Compared with the NAT, expression of let-7 was significantly lower in ESCC tissues (P < 0.05), and there was a significant correlation between low expression of let-7 and lymph node metastasis in ESCC (P < 0.05). Moreover, the protein expression of HMGA2 was significantly higher in ESCC compared with NAT (P < 0.05). However, mRNA expression of HMGA2 had no obvious significance between them. The present results demonstrated that let-7 and HMGA2 involved in ESCC carcinogenesis. Let-7 could inhibit cell proliferation and lower expressed in ESCC, and there was a correlation between let-7 lower expression and lymph node metastasis in ESCC patients. As well as, HMGA2 protein expression was significantly higher in ESCC than that in NAT, and HMGA2 may negatively regulated by let-7 at the post- transcriptional level in ESCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598109     DOI: 10.1007/s11033-011-0854-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  27 in total

1.  Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation.

Authors:  Yong Sun Lee; Hak Kyun Kim; Sangmi Chung; Kwang-Soo Kim; Anindya Dutta
Journal:  J Biol Chem       Date:  2005-02-18       Impact factor: 5.157

2.  An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China.

Authors:  Na Wang; Xiu-Juan Dong; Rong-Miao Zhou; Wei Guo; Xiao-Juan Zhang; Yan Li
Journal:  Mol Biol Rep       Date:  2007-11-29       Impact factor: 2.316

3.  Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China.

Authors:  Yan Li; Dong-lan Sun; Ya-nan Duan; Xiao-juan Zhang; Na Wang; Rong-miao Zhou; Zhi-feng Chen; Shi-jie Wang
Journal:  Mol Biol Rep       Date:  2009-06-28       Impact factor: 2.316

4.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

5.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

6.  let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Tomoki Naoe
Journal:  Biol Pharm Bull       Date:  2006-05       Impact factor: 2.233

7.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

8.  Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.

Authors:  Kazuo Motoyama; Hiroshi Inoue; Yoshito Nakamura; Hiroyuki Uetake; Kenichi Sugihara; Masaki Mori
Journal:  Clin Cancer Res       Date:  2008-04-15       Impact factor: 12.531

9.  MicroRNAs involved in neoplastic transformation of liver cancer stem cells.

Authors:  Ren Li; Niansong Qian; Kaishan Tao; Nan You; Xinchuan Wang; Kefeng Dou
Journal:  J Exp Clin Cancer Res       Date:  2010-12-23

10.  High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma.

Authors:  Carla Hebert; Kathleen Norris; Mark A Scheper; Nikolaos Nikitakis; John J Sauk
Journal:  Mol Cancer       Date:  2007-01-14       Impact factor: 27.401

View more
  26 in total

Review 1.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

Review 2.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 3.  Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.

Authors:  Christine Kestens; Peter D Siersema; Jantine W P M van Baal
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.

Authors:  Thomas X Lu; Joseph D Sherrill; Ting Wen; Andrew J Plassard; John A Besse; Juan Pablo Abonia; James P Franciosi; Philip E Putnam; Michael Eby; Lisa J Martin; Bruce J Aronow; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2012-03-03       Impact factor: 10.793

Review 5.  MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.

Authors:  J Huang; S-Y Zhang; Y-M Gao; Y-F Liu; Y-B Liu; Z-G Zhao; K Yang
Journal:  Cell Prolif       Date:  2014-06-06       Impact factor: 6.831

6.  Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease.

Authors:  Wen-Jing Liu; Qian Xu; Li-Ping Sun; Qi-Guan Dong; Cai-Yun He; Yuan Yuan
Journal:  Tumour Biol       Date:  2014-12-31

Review 7.  MicroRNA involvement in esophageal carcinogenesis.

Authors:  Stefan David; Stephen J Meltzer
Journal:  Curr Opin Pharmacol       Date:  2011-10-10       Impact factor: 5.547

8.  Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.

Authors:  Chun-Hui Wei; Li-Xiu Wei; Ming-Yu Lai; Jia-Zhuang Chen; Xi-Jing Mo
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

9.  Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.

Authors:  L Yan; J Zhou; Y Gao; S Ghazal; L Lu; S Bellone; Y Yang; N Liu; X Zhao; A D Santin; H Taylor; Y Huang
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

10.  miR-let-7a-5p Inhibits Invasion and Migration of Hepatoma Cells by Regulating BZW2 Expression.

Authors:  Ling Liu; Jinfeng Zhao; Ying Peng; Manyi Yang; Lihua Zhang; Xin Jin
Journal:  Onco Targets Ther       Date:  2020-11-27       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.